Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
Carol Sullivan, MS, RD, CSO, LDN
Contributor
Carol Sullivan, MS, RD, CSO, LDN is a senior dietitian at Massachusetts General Hospital (MGH). She has more than 15 years of experience in the field, including more than a decade practicing as a Certified Specialist in Oncology Nutrition. At MGH she has been fortunate to work with many people and their loved ones undertaking the scary world of a cancer diagnosis, and treatment. Her pragmatic, evidenced based and individualized approach to nutrition has helped many thrive through the challenges of treatment and the often-confusing time after treatments are complete. She sees patients in survivorship through the MGH Cancer Center Oncology Lifestyle Medicine program to help people make positive nutrition and health behavior change. Carol is passionate about helping people see the good in food. At home she loves spending time in the kitchen and outside with her 2 young boys.
Posts by Carol Sullivan, MS, RD, CSO, LDN
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine